- BACB announces Damian Austin as new Chief Executive
- Beyond the Pitch Deck: What Investor Readiness Really Means
- How to Strengthen Your Business IT for Lasting Security and Growth
- Cutting the cost of Africa’s energy transition with the right flexibility mix - Kenneth Engblom Vice President, Wartsila Energy, Europe and Africa
- Ghana International Bank announces Ian Greenstreet as its new Chief Executive Officer
Novartis Speeds New Anti-Malarial as Older Drug Loses Potency
LAGOS (Capital Markets in Africa) – Novartis AG began testing a new anti-malaria pill in Africa, advancing development of an alternative to its most effective treatment that billionaire philanthropist Bill Gates said risked losing potency. Patients in Mali infected with the mosquito-borne parasite began receiving the experimental drug, known as KAF156, in combination with another medicine, the drugmaker said Monday. More than 500 children and adults across nine countries in Africa and Asia will be enrolled in the mid-stage study…
Read More




